Collectively, our study suggests that NRP1 expression could act as an effective prognostic marker by predicting the infiltration of Treg cells and M2 macrophages, indicating the role of NRP1 as a prognosis biomarker in patients with STAD. Here, NRP1 is linked to gastric adenocarcinoma.